A Form 4 filed on November 6, 2026 with the SEC discloses that Jaime A. Irick, President and CEO of Transcat, Inc. (NASDAQ:TRNS), purchased 2,275 shares of common stock on November 5, 2026 at a weighted average price of $101.26 per share.

Key Highlights

  • Purchase transaction: Jaime A. Irick acquired 2,275 shares of Transcat common stock ($.50 par value) on November 5, 2026, coded as a purchase (P).
  • Weighted average price: The reported price of $101.26 per share reflects a weighted average across multiple transactions ranging from $100.89 to $101.35.
  • Resulting direct ownership: Following the transaction, Irick directly beneficially owns 2,275 shares of common stock.
  • Restricted stock units held: Irick also holds 15,043 restricted stock units, each converting into one share of common stock, vesting on March 31, 2029.
  • Role: Irick is identified in the filing as both a Director and an Officer, serving as President and CEO of Transcat, Inc.

CEO Irick's Open-Market Purchase and Existing Equity Holdings at Transcat

According to the filing, Jaime A. Irick, President and CEO of Transcat, Inc., acquired 2,275 shares of Transcat common stock (par value $.50 per share) on November 5, 2026 through an open-market purchase. The transaction was assigned code "P" in the filing. The price of $101.26 is described as a weighted average, with individual transactions executed at prices ranging from $100.89 to $101.35. The filing notes that Irick "undertakes to provide to Transcat, Inc., any security holder of Transcat, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."

Following the reported transaction, Irick's direct beneficial ownership of Transcat common stock stands at 2,275 shares, as reported in Table I of the filing. In addition, Table II of the filing discloses that Irick holds 15,043 restricted stock units (RSUs), which convert into Transcat common stock on a one-for-one basis. According to the filing, these RSUs "vest on March 31, 2029, except as otherwise provided in the award notice," and are held directly with a conversion or exercise price of $0.

The Form 4 was signed on November 6, 2026 by Kristina L. Johnston as Attorney-in-Fact for Jaime A. Irick and filed with the SEC that same date. No amendment date is listed, indicating this is not an amended filing. The filing does not indicate that the purchase was made pursuant to a Rule 10b5-1 trading plan.

What Was Disclosed

Transcat, Inc. (NASDAQ:TRNS) President and CEO Jaime A. Irick reported an open-market purchase of 2,275 shares of common stock on November 5, 2026 at a weighted average price of $101.26 per share, plus existing holdings of 15,043 restricted stock units vesting March 31, 2029.